| # | Drug | Count |
|---|---|---|
| 0 | ETONOGESTREL AND ETHINYL ESTRADIOL | 4 |
| 1 | ALEMTUZUMAB | 2 |
| 2 | MEDROXYPROGESTERONE ACETATE | 2 |
| 3 | METHOTREXATE | 2 |
| 4 | METHOTREXATE SODIUM | 2 |
| 5 | PREDNISONE | 2 |
| 6 | ADALIMUMAB | 1 |
| 7 | ALBUTEROL | 1 |
| 8 | ALBUTEROL SULFATE | 1 |
| 9 | ALENDRONATE SODIUM | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FENOPROFEN CALCIUM | 1 | 0.0204 |
| 1 | DESOGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0003 |
| 2 | ETONOGESTREL AND ETHINYL ESTRADIOL | 4 | 0.0002 |
| 3 | NABUMETONE | 1 | 0.0002 |
| 4 | ALEMTUZUMAB | 2 | 0.0001 |
| 5 | PROGESTERONE | 1 | 0.0000 |
| 6 | SUMATRIPTAN | 1 | 0.0000 |
| 7 | COPPER | 1 | 0.0000 |
| 8 | DROSPIRENONE AND ETHINYL ESTRADIOL | 1 | 0.0000 |
| 9 | ECULIZUMAB | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Estrogen [EPC] | 5 |
| 1 | Progestin [EPC] | 4 |
| 2 | Corticosteroid [EPC] | 3 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 2 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 2 |
| 5 | Antirheumatic Agent [EPC] | 1 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 1 |
| 7 | Calcium [EPC] | 1 |
| 8 | Complement Inhibitor [EPC] | 1 |
| 9 | Copper-containing Intrauterine Device [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 1 | Progesterone [EPC] | 1 | 0.0000 |
| 2 | Estrogen [EPC] | 5 | 0.0000 |
| 3 | Copper-containing Intrauterine Device [EPC] | 1 | 0.0000 |
| 4 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Progestin [EPC] | 4 | 0.0000 |
| 6 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Antirheumatic Agent [EPC] | 1 | 0.0000 |
| 8 | Calcium [EPC] | 1 | 0.0000 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 2 | 0.0000 |